|Selective estrogen receptor modifier (RAL), Anti-sclerostin (ROM)|We conditionally recommend IV BP, ROM, RAL over no treatment in high and very high risk of fracture. Except in patients intolerant of other agents, we conditionally recommend against RAL due to harms of VTE and fatal stroke or ROM due to uncertain harms including increased myocardial infarction, stroke and death.|-|</p>